![]() |
市場調查報告書
商品編碼
1776213
子宮內壓導管的全球市場:洞察,競爭情形,市場預測:2032年Intrauterine Pressure Catheter - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
預計在2025年至2032年的預測期內,子宮內壓力導管市場將以6.53%的複合年增長率成長。包括早產和胎兒窘迫等併發症的發生率不斷上升,推動了對精準監護解決方案的需求,以確保最佳的母嬰結果。同時,發展中地區出生率的上升也擴大了對先進醫療技術的需求,包括子宮內壓力導管。此外,人們對胎兒監護重要性的認識日益加深,凸顯了對準確、即時宮縮數據的需求,這進一步推動了市場的發展。此外,主要市場參與者產品開發活動的激增,推動了導管技術的創新進步,增強了其功能性和吸引力。總體而言,這些因素預計將在2025年至2032年的預測期內推動子宮內壓力導管市場的發展。
子宮內壓力導管市場動態:
根據世界衛生組織 (WHO) 提供的最新數據和統計數據(2023年),全球估計有1340萬嬰兒早產。早產通常以子宮收縮不規則或不足為特徵,這可能導致母親和嬰兒出現併發症。在這種情況下,準確監測子宮活動對於評估分娩進展和確定適當的臨床幹預措施至關重要。子宮內壓力導管 (IUPC) 可以即時準確測量子宮內壓力,使醫護人員能夠密切監測宮縮的強度和頻率。這對於外部方法效果較差的早產尤其重要,從而推動全球子宮內壓力導管 (IUPC) 市場的整體擴張。
此外,妊娠糖尿病會增加懷孕和分娩期間併發症的風險,包括胎兒過度生長(巨大兒),這可能導致分娩延遲,並需要剖腹產等乾預措施。例如,根據國際糖尿病聯盟 (International Diabetes Federation) 提供的最新數據(2025 年),2024 年妊娠期糖尿病的患病率在全球範圍內存在差異:非洲估計約為 10.8%,歐洲約為 13.9%,澳大利亞約為 14.9%,法國約為 10.7%,印度約 2617%,約 3.3%。準確監測宮縮對於妊娠糖尿病女性的分娩管理至關重要,因為分娩過程中可能會出現併發症,需要及時且有針對性的干預。 此外,新興國家出生率的上升和胎兒監護意識的提高也是推動子宮內壓力監測市場發展的主要因素。發展中地區出生率的上升促使人們更加重視改善孕產婦和新生兒醫療保健基礎設施。這些國家正在投資建造更完善的醫療設施和技術,以應對日益增長的懷孕數量,這增加了對子宮內壓力監測等先進監測解決方案的需求。同時,人們越來越意識到胎兒監護的重要性,尤其是在分娩過程中,因為子宮腔功能不全和胎兒窘迫等併發症如果不能及早發現,可能會造成嚴重後果。子宮內壓力監測器能夠提供即時、準確的宮縮數據,使醫護人員能夠在出現併發症時迅速乾預,從而推動全球宮內壓力導管市場的整體成長。
此外,主要市場參與者的加入也進一步促進了子宮內壓力導管市場的成長。 CooperSurgical 是婦產科器材市場的主要參與者,佔據主導地位。其子宮內壓力導管 (IUPC) 產品 Intran Plus™ 和 Intran Plus™ 拋棄式子宮內壓力導管 (IUPC) 以其在分娩過程中精確的子宮內壓力測量而聞名。該公司廣泛的醫院網絡、持續的技術創新以及對婦產科的專注,有力地推動了產品在產科病房的普及,顯著提升了其全球市場滲透率。
因此,預計上述因素將在2025年至2032年的預測期內推動整個子宮內壓力導管市場的發展。
然而,有限的使用案例(例如感染和不適的風險,以及子宮膜破裂、胎盤異常和某些疾病的女性不適合插入子宮內壓力導管)可能會限制子宮內壓力導管市場的成長。
子宮內壓力導管市場區隔分析:
在子宮內壓力導管市場中,預計到2024年,換能器尖端導管類別將佔據最大的市場佔有率。換能器尖端導管憑藉其先進的技術和更高的宮縮監測精度,在推動整個子宮內壓力導管 (IUPC) 市場發展方面發揮關鍵作用。換能器尖端導管在導管尖端裝有感測器,可直接測量子宮內壓力。這項技術消除了氣泡和其他幹擾液體系統精確度的問題,從而提供了更可靠的子宮內活動數據。換能器尖端導管提供的即時、精確測量數據,提高了醫護人員監測分娩進展、及早發現併發症以及做出明智臨床決策的能力。此外,這些導管的易用性和更佳性能使其對醫護專業人員更具吸引力,從而在醫院和分娩中心中廣泛應用。
隨著醫療機構持續將病患安全和結果準確性放在首位,對帶探頭的子宮內壓力導管 (IUPC) 的需求也日益增長,從而推動了子宮內壓力導管市場的整體成長。它們能夠在高風險妊娠(精準數據至關重要)中提供卓越的監測能力,進一步鞏固了其作為市場擴張催化劑的作用。例如,Clinical Innovations(Laborie 品牌)的 Koala® 宮內壓力導管就是一個值得關注的帶探頭導管示例,它能夠以極低的測量誤差風險提供精準的宮內壓力測量。同樣,美敦力的 INTRAN™ Plus 一次性子宮內壓力導管旨在簡化插入過程,並透過內建探頭提供可靠的測量。這些技術創新與醫院減少臨床醫生工作量、提高病人安全性和減少介入相關併發症的目標一致。
因此,預計上述所有因素都將為該領域帶來可觀的收入,從而在預測期內推動全球宮內壓力導管市場的整體成長。
在所有地區中,預計北美將在2024年佔據全球子宮內壓力導管市場的最大佔有率。子宮內壓力導管市場的主要驅動因素包括早產患病率上升、妊娠併發症增加、公眾對分娩期間母嬰安全意識的提高、對新型先進產品的需求不斷增長、微創手術的採用率不斷提高,以及在該地區開展戰略活動的大型公司的存在。
根據美國疾病管制與預防中心 (CDC) (2024) 提供的數據,2022 年美國的出生率為每千人口 11 例,15-44 歲女性的出生率為每千名女性 56.3 例。高出生率意味著許多懷孕需要仔細監測,以避免延遲分娩、子宮腔功能不全和胎兒生長受限等併發症。隨著醫療保健提供者努力改善產婦和新生兒的預後,他們擴大採用子宮內壓力導管 (IUPC) 來確保在分娩期間進行更好的控制和管理,這有望推動整個地區宮內壓力導管市場的發展。
此外,根據美國疾病管制與預防中心 (CDC) 提供的最新數據(2023 年),2021 年被診斷患有妊娠糖尿病(妊娠期糖尿病)的孕婦比例從 6.0% 上升至 8.3%。子宮內壓力導管 (IUPC) 提供準確、即時的子宮內壓力數據,使醫療保健提供者能夠發現異常並及時應對。全球妊娠糖尿病病例的增加,尤其是隨著孕婦年齡和肥胖程度的增加,預計將推動對 IUPC 等先進監測解決方案的需求,並推動市場擴張。
此外,該地區女性人口的成長也將推動對子宮內壓力導管的需求。例如,根據世界衛生組織 (WHO) 發布的最新數據 (2022 年),只要提高認識並讓孕婦獲得優質護理,美國約有一半的孕產婦死亡是可以預防的。此外,多達 5 萬名婦女可能在懷孕、分娩和產後期間出現嚴重併發症。這些統計數據凸顯了改善孕產婦監測和優質產科護理的迫切需求,直接支持了對子宮內壓力導管 (IUPC) 日益增長的需求。美國約有一半的孕產婦死亡是可以預防的,這一事實凸顯了及時準確的分娩監測的關鍵作用,IUPC 可以透過提供子宮收縮的即時數據並幫助預防子宮破裂和分娩進展不足等併發症,在這一領域發揮重要作用。
因此,預計上述所有因素的相互作用將在預測期內推動北美子宮內壓力導管市場的發展。
子宮內壓力導管市場的主要公司:
子宮內壓力導管市場的主要參與者包括:Cardinal Health、Koninklijke Philips N.V.、Utah Medical Products, Inc.、CooperSurgical Inc.、Thomas Medical、VYAIRE、Laborie、LABOTECT GMBH、Kentec Medical, Inc.、通用電氣公司、Famasys Inc. 和微創醫療科學有限公司。
子宮內壓力導管市場的最新發展:
子宮內避孕導管市場研究報告重點
子宮內壓力導管市場常見問題
Intrauterine Pressure Catheters (IUPCs) Market by Product (Fluid-Filled Catheters and Transducer Tip Catheters), End-User (Hospitals, Ambulatory Surgical Centers (ASCS), and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of complicated pregnancies, rising birth rates in developing regions, growing awareness of fetal monitoring, and increase in product development activities by key market players across the globe.
The intrauterine pressure catheters market is estimated to grow at a CAGR of 6.53% during the forecast period from 2025 to 2032. The rising incidence of complicated pregnancies, including conditions like preterm labor and fetal distress, drives the demand for precise monitoring solutions to ensure optimal maternal and fetal outcomes. Concurrently, increasing birth rates in developing regions are expanding the need for advanced healthcare technologies, including intrauterine pressure catheters. Additionally, the growing awareness of the importance of fetal monitoring underscores the necessity for accurate and real-time data on uterine contractions, further propelling the market. Furthermore, the surge in product development activities by key market players is leading to innovative advancements in catheter technology, which enhances their functionality and appeal. Collectively, these factors are expected to boost the market for intrauterine pressure catheters during the forecast period from 2025 to 2032.
Intrauterine Pressure Catheters Market Dynamics:
According to the recent data and stats provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm across the globe. Preterm labor often involves irregular or insufficient uterine contractions, which can lead to complications for both the mother and the baby. In such cases, precise monitoring of uterine activity is crucial to assess labor progression and determine the appropriate clinical interventions. IUPCs provide accurate, real-time measurement of intrauterine pressure, allowing healthcare providers to closely monitor the strength and frequency of contractions, which is particularly important in preterm labor where external methods may be less effective thereby escalating the overall market of IUPCs across the globe.
Furthermore, gestational diabetes increases the risk of complications during pregnancy and labor, including excessive fetal growth (macrosomia), which can lead to prolonged labor or the need for interventions such as C-sections. For instance, as per the latest data provided by the International Diabetes Federation (2025), in 2024 gestational diabetes mellitus rates varied globally, with approximately 10.8% reported in Africa, 13.9% in Europe, 14.9% in Australia, 10.7% in France, 26.1% in India, 37.6% in Spain, and 23.1% in the United Kingdom. Thus, accurate monitoring of uterine contractions becomes crucial in managing labor for women with gestational diabetes, as complications can arise during delivery that require timely and precise interventions.
Furthermore, the rising birth rates in developing regions and growing awareness of fetal monitoring are other key factors collectively driving the market for intrauterine pressure monitors. In developing regions, increasing birth rates are putting more focus on improving maternal and neonatal healthcare infrastructure. As these countries invest in better medical facilities and technologies to manage the growing number of pregnancies, the demand for advanced monitoring solutions, like intrauterine pressure monitors, is on the rise. At the same time, there is a heightened awareness of the importance of fetal monitoring, especially during labor, as complications like uterine dysfunction and fetal distress can lead to severe outcomes if not detected early. Intrauterine pressure monitors provide real-time, accurate data on uterine contractions, enabling healthcare providers to intervene swiftly when complications arise thereby boosting the overall market of intrauterine pressure catheters across the globe.
Additionally, the presence of key market players is further contributing to the growth of intrauterine pressure catheters. Major player CooperSurgical which is a dominant player in the obstetrics and gynecology device market. Their IUPCs such as Intran Plus(TM), and Intran Plus(TM) Disposable IUPC are known for accuracy in intrauterine pressure measurement during labor. The company's broad hospital network, continuous innovation, and OB-GYN focus drive strong product adoption in maternity wards, significantly boosting market penetration worldwide.
Thus, the factors mentioned above are expected to boost the overall market of intrauterine pressure catheters during the forecast period from 2025 to 2032.
However, the risk of infection and discomfort and limited use in certain cases such as women with ruptured membranes, placental abnormalities, or certain medical conditions may not be candidates for IUPC insertion thus, these may be the limiting factors for the intrauterine pressure catheters market growth.
Intrauterine Pressure Catheters Market Segment Analysis:
Intrauterine Pressure Catheters (IUPCs) Market by Product (Fluid-Filled Catheters and Transducer Tip Catheters), End-User (Hospitals, Ambulatory Surgical Centers (ASCS), and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the intrauterine pressure catheters market, the transducer tip catheters category is expected to hold the largest share in the year 2024. Transducer tip catheters are playing a significant role in boosting the overall market of intrauterine pressure catheters (IUPCs) due to their advanced technology and enhanced accuracy in monitoring uterine contractions. Transducer tip catheters feature a built-in sensor at the catheter's tip, which allows for direct measurement of intrauterine pressure. This technology eliminates the risk of air bubbles and other issues that can interfere with the accuracy of fluid-based systems, providing more reliable data on uterine activity. The real-time, precise readings offered by transducer tip catheters improve the ability of healthcare providers to monitor labor progression, detect complications early, and make informed clinical decisions. Additionally, the ease of use and improved performance of these catheters have made them more appealing to medical professionals, leading to increased adoption in hospitals and birthing centers.
As healthcare facilities continue to prioritize patient safety and outcome accuracy, the demand for transducer tip IUPCs is rising, contributing to the overall growth of the IUPC market. Their ability to offer superior monitoring capabilities in high-risk pregnancies, where accurate data is crucial, further solidifies their role in driving market expansion. For instance, Koala(R) Intrauterine Pressure Catheter by Clinical Innovations (a Laborie brand) is a prominent example of a transducer tip catheter that offers accurate uterine pressure readings with minimal risk of measurement error. Similarly, the INTRAN(TM) Plus Disposable IUPC by Medtronic is designed to simplify insertion and deliver reliable readings with an internal transducer tip. These innovations help reduce clinician workload, improve patient safety, and align with hospital goals of reducing intervention-related complications.
Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global intrauterine pressure catheters market during the forecast period.
North America is expected to dominate the overall intrauterine pressure catheters market:
Among all the regions, North America is expected to hold the largest share of the global intrauterine pressure catheters market in 2024. The key driving factors of the intrauterine pressure catheters market are the increasing prevalence of preterm birth, increasing complications in pregnancies, increasing awareness among the people about the safety of mother and child during the delivery, growing demand for new and advanced products, increased adoption of minimally invasive procedure, and the presence of key players engaged in strategic activities in the region.
According to the data provided by the Centers for Disease Control and Prevention (CDC) (2024), in 2022, the birth rate was 11 per 1000 people and the fertility rate was 56.3 births per 1000 women aged between 15-44 in the United States. Higher birth rates mean more pregnancies that may require careful monitoring to avoid complications such as prolonged labor, uterine dysfunction, or fetal distress. As healthcare providers strive to improve maternal and neonatal outcomes, they increasingly adopt IUPCs to ensure better control and management during childbirth thereby the market of intrauterine pressure catheters is expected to boost across the region.
Additionally, as per the recent data provided by the Centre for Disease Control and Prevention (2023), the percentage of mothers giving birth who received a diagnosis of diabetes during pregnancy (gestational diabetes) increased from 6.0% to 8.3% in 2021. IUPCs provide accurate, real-time data on uterine pressure, allowing healthcare providers to detect any irregularities and respond promptly. As gestational diabetes cases rise globally, especially with increasing maternal age and obesity, the demand for advanced monitoring solutions like IUPCs is expected to grow, driving market expansion.
Furthermore, the growing female population in the region will in turn propel the demand for intrauterine pressure catheters. For instance, according to the latest data presented by the World Health Organization (WHO) (2022), about half of maternal deaths in the United States were preventable, so long as there's increased awareness and pregnant women can get access to quality care. Also, Up to 50,000 women may experience severe complications during pregnancy, at delivery, or in the postpartum period. These statistics highlight the urgent need for improved maternal monitoring and quality obstetric care, directly supporting the growing demand for intrauterine pressure catheters (IUPCs). The fact that half of maternal deaths in the U.S. are preventable underscores the critical role of timely and accurate labor monitoring in an area where IUPCs can make a substantial impact by providing real-time data on uterine contractions, helping to prevent complications such as uterine rupture or inadequate labor progression.
Hence, the interplay of all the above-mentioned factors is anticipated to augment the market for intrauterine pressure catheters in the region during the forecasted period in North America.
Intrauterine Pressure Catheters Market Key Players:
Some of the key market players operating in the intrauterine pressure catheters market include Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Thomas Medical, VYAIRE, Laborie, LABOTECT GMBH, Kentec Medical, Inc., General Electric Company, Femasys Inc., MicroPort Scientific Corporation, and others.
Recent Developmental Activities in the Intrauterine Pressure Catheters Market:
Key takeaways from the intrauterine pressure catheters market report study:
Target audience who can benefit from this intrauterine pressure catheters market report study:
Frequently Asked Questions for the Intrauterine Pressure Catheters Market: